-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
It is well known that hepatocellular carcinoma (HCC) has high morbidity and mortality worldwide .
It is well known that hepatocellular carcinoma (HCC) has high morbidity and mortality worldwide .
The optimal treatment strategy for early and very early HCC remains controversial
This study evaluated interventions for HCC patients in a tertiary hepatobiliary center .
This study evaluated interventions for HCC patients in a tertiary hepatobiliary center .
After TA, 100 patients (56-8%) developed recurrent HCC, of whom 76 (76-0%) received up to 4 repeat interventions
This study found that TA is an effective treatment modality for both primary and recurrent HCC
Original source:
Christiaan MC Serbanescu-Kele Apor de Zalán, Simeon JS Ruiter, Aad P van den Berg, et al.
Christiaan MC Serbanescu-Kele Apor de Zalán, Simeon JS Ruiter, Aad P van den Berg, et al.
Outcomes after primary and repeat thermal ablation of hepatocellular carcinoma with or without liver transplantation .
DOI : 10.
1007/s00330-021-08515-3 Outcomes after primary and repeat thermal ablation of hepatocellular carcinoma with or without liver transplantation 10.
1007/s00330-021-08515-3
Leave a comment here